Delivery Order SPE2DX22D0010-SPE2D826FAR24
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Metadate CD Caps 20mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $5,961.67, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $16,551.16, represents a non-competitive set-aside award and is scheduled for completion by August 19, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,784.33 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This competitive award, issued on May 30, 2025, represents a firm fixed-price delivery order with a completion deadline of June 2, 2025. The contract carries no small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,516.09 delivery order to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on June 27, 2025, with an ultimate completion date of June 30, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Metadate CD Caps 20mg, a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,322.65 with an ultimate completion date of April 25, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's Corporate Office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Metadate CD Caps 30mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $8,397.85 with a completion deadline of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,749.22 to AmerisourceBergen Drug Corp for Metadate CD Caps 20mg, a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This non-competitive, firm fixed-price delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Metadate CD Caps 20mg, a central nervous system stimulant medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with a ceiling value of $5,438.69 and an ultimate completion date of April 24, 2025. The performance location is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Metadate CD Caps 10mg, a medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order carries a ceiling value of $2,541.81 and is scheduled for completion by August 27, 2025. The contract was awarded on a competitive basis with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 6, 2025, for the supply of Metadate CD Caps 10mg, a medication used to treat attention-deficit/hyperactivity disorder. This is a firm fixed-price delivery order with a ceiling value of $3,203.63 and an ultimate completion date of October 7, 2025. The award is unclassified as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAR24Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metadate CD Caps 10mg, a central nervous system stimulant medication commonly prescribed for attention deficit hyperactivity disorder. The contract, valued at $1,832.33, is structured as a firm fixed price delivery order with an ultimate completion date of October 29, 2025. This is a competitively awarded, non-set-aside contract with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen's established role as a major pharmaceutical distributor positions it to fulfill federal medical procurement requirements across multiple therapeutic domains for defense and healthcare system customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/28/25 |